{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:02:55Z","timestamp":1791558175242,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1101HX002798-01A1"],"award-info":[{"award-number":["1101HX002798-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11606-024-09346-w","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T16:33:48Z","timestamp":1738168428000},"page":"1811-1819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Engaging Patients in Discussions About Medication Deprescribing"],"prefix":"10.1007","volume":"40","author":[{"given":"Jacquelyn","family":"Pendergast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie B.","family":"Wormwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stolzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Fitzgerald","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Still","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bokhour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Linsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"9346_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatrics. 2017;17:1-10.","journal-title":"BMC Geriatrics."},{"key":"9346_CR2","doi-asserted-by":"publisher","first-page":"204209862093374","DOI":"10.1177\/2042098620933741","volume":"11","author":"M Khezrian","year":"2020","unstructured":"Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeut Adv Drug Saf. 2020;11:2042098620933741.","journal-title":"Therapeut Adv Drug Saf."},{"issue":"1","key":"9346_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65.","journal-title":"Expert Opin Drug Saf."},{"issue":"5","key":"9346_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Int Med. 2015;175(5):827-834.","journal-title":"JAMA Int Med."},{"key":"9346_CR5","doi-asserted-by":"crossref","unstructured":"Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. \u201cI don\u2019t know how many of these [medicines] are necessary..\u201d\u2014A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74(2):135\u2013141.","DOI":"10.1016\/j.pec.2008.08.019"},{"issue":"2","key":"9346_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pec.2014.11.010","volume":"98","author":"A Linsky","year":"2015","unstructured":"Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98(2):220-225.","journal-title":"Patient Educ Couns."},{"issue":"4","key":"9346_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ppar\/pry030","volume":"28","author":"A Linsky","year":"2018","unstructured":"Linsky A, Zimmerman KM. Provider and system-level barriers to deprescribing: interconnected problems and solutions. Public Policy Aging Rep. 2018;28(4):129-133.","journal-title":"Public Policy Aging Rep."},{"issue":"4","key":"9346_CR8","first-page":"277","volume":"21","author":"A Linsky","year":"2015","unstructured":"Linsky A, Simon SR, Marcello TB, Bokhour B. Clinical provider perceptions of proactive medication discontinuation. Am J Manag Care. 2015;21(4):277-283.","journal-title":"Am J Manag Care."},{"issue":"11","key":"9346_CR9","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1111\/jgs.17974","volume":"70","author":"A Hung","year":"2022","unstructured":"Hung A, Sloan CE, Boyd C, Bayliss EA, Hastings SN, Maciejewski ML. Deprescribing medications: Do out-of-pocket costs have a role? J Am Geriatr Soc. 2022;70(11):3334.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"9346_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmacy7030129","volume":"7","author":"K Le Bosquet","year":"2019","unstructured":"Le Bosquet K, Barnett N, Minshull J. Deprescribing: Practical ways to support person-centred, evidence-based deprescribing. Pharmacy. 2019;7(3):129.","journal-title":"Pharmacy."},{"issue":"1","key":"9346_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40545-023-00671-9","volume":"16","author":"S Alrawiai","year":"2023","unstructured":"Alrawiai S. Deprescribing, shared decision-making, and older people: perspectives in primary care. J Pharm Policy Pract. 2023;16(1):153.","journal-title":"J Pharm Policy Pract."},{"key":"9346_CR12","unstructured":"Dang S. Shared Decision Making-The Pinnacle of Patient-Centered Care. J Indian Acad Geriatr. 2018;14."},{"issue":"3","key":"9346_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pec.2005.06.010","volume":"60","author":"G Makoul","year":"2006","unstructured":"Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60(3):301-312.","journal-title":"Patient Educ Couns."},{"key":"9346_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11606-007-0149-9","volume":"22","author":"L Fraenkel","year":"2007","unstructured":"Fraenkel L, McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Int Med. 2007;22:614-619.","journal-title":"J Gen Int Med."},{"key":"9346_CR15","doi-asserted-by":"crossref","unstructured":"Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. Bmj. 2016;353.","DOI":"10.1136\/bmj.i2893"},{"issue":"4","key":"9346_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence\u2010based, patient\u2010centred deprescribing process. British J Clin Pharmacol. 2014;78(4):738-747.","journal-title":"British J Clin Pharmacol."},{"key":"9346_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-80","volume":"14","author":"P Martin","year":"2013","unstructured":"Martin P, Tamblyn R, Ahmed S, Tannenbaum C. An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial. Trials. 2013;14:1-11.","journal-title":"Trials."},{"issue":"7","key":"9346_CR18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/bcp.13912","volume":"85","author":"MA Fajardo","year":"2019","unstructured":"Fajardo MA, Weir KR, Bonner C, Gnjidic D, Jansen J. Availability and readability of patient education materials for deprescribing: an environmental scan. British J Clin Pharmacol. 2019;85(7):1396-1406.","journal-title":"British J Clin Pharmacol."},{"issue":"6","key":"9346_CR19","first-page":"559","volume":"9","author":"A Mack","year":"2003","unstructured":"Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm. 2003;9(6):559-568.","journal-title":"J Manag Care Pharm."},{"issue":"7","key":"9346_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/AJP.0000000000000014","volume":"30","author":"PZ Yan","year":"2014","unstructured":"Yan PZ, Butler PM, Kurowski D, Perloff MD. Beyond neuropathic pain: gabapentin use in cancer pain and perioperative pain. Clin J Pain. 2014;30(7):613-629.","journal-title":"Clin J Pain."},{"issue":"601","key":"9346_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3399\/bjgp12X653516","volume":"62","author":"BH Smith","year":"2012","unstructured":"Smith BH, Higgins C, Baldacchino A, Kidd B, Bannister J. Substance misuse of gabapentin. Br J Gen Pract. 2012;62(601):406-407.","journal-title":"Br J Gen Pract."},{"issue":"5","key":"9346_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","volume":"28","author":"A Hypoglycemia","year":"2005","unstructured":"Hypoglycemia A. Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005;28(5):1245.","journal-title":"Diabetes Care."},{"issue":"6","key":"9346_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Int Med. 2014;174(6):890-898.","journal-title":"JAMA Int Med."},{"issue":"1","key":"9346_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pec.2013.02.016","volume":"92","author":"P Martin","year":"2013","unstructured":"Martin P, Tamblyn R, Ahmed S, Tannenbaum C. A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly. Patient Educ Couns. 2013;92(1):81-87.","journal-title":"Patient Educ Couns."},{"key":"9346_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-015-0791-1","volume":"16","author":"P Martin","year":"2015","unstructured":"Martin P, Tamblyn R, Ahmed S, Benedetti A, Tannenbaum C. A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial. Trials. 2015;16:1-11.","journal-title":"Trials."},{"key":"9346_CR26","doi-asserted-by":"crossref","unstructured":"Epstein RM, Street Jr RL. Patient-centered communication in cancer care: promoting healing and reducing suffering. 2007.","DOI":"10.1037\/e481972008-001"},{"key":"9346_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40271-015-0131-2","volume":"8","author":"CC Duke","year":"2015","unstructured":"Duke CC, Lynch WD, Smith B, Winstanley J. Validity of a new patient engagement measure: the Altarum Consumer Engagement (ACE) Measure\u2122. Patient-Patient-Centered Outcome Res. 2015;8:559-568.","journal-title":"Patient-Patient-Centered Outcome Res."},{"issue":"12","key":"9346_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40266-020-00802-w","volume":"37","author":"AM Linsky","year":"2020","unstructured":"Linsky AM, Stolzmann K, Meterko M. The patient perceptions of deprescribing (PpoD) survey: short-form development. Drugs Aging. 2020;37(12):909-916.","journal-title":"Drugs Aging."},{"key":"9346_CR29","first-page":"2366","volume":"32","author":"SN Hoddinott","year":"1986","unstructured":"Hoddinott SN, Bass MJ. The dillman total design survey method. Can Fam Physician. 1986;32:2366.","journal-title":"Can Fam Physician."},{"issue":"10","key":"9346_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/MCG.0000000000001317","volume":"54","author":"N Nallapeta","year":"2020","unstructured":"Nallapeta N, Reynolds JL, Bakhai S. Deprescribing proton pump inhibitors in an academic, primary care clinic: quality improvement project. J Clinical Gastroenterol. 2020;54(10):864-870.","journal-title":"J Clinical Gastroenterol."},{"key":"9346_CR31","doi-asserted-by":"publisher","first-page":"204209862211164","DOI":"10.1177\/20420986221116465","volume":"13","author":"KM Lukacena","year":"2022","unstructured":"Lukacena KM, Keck JW, Freeman PR, Harrington NG, Huffmyer MJ, Moga DC. Patients\u2019 attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists. Ther Adv Drug Saf. 2022;13:20420986221116465.","journal-title":"Ther Adv Drug Saf."},{"key":"9346_CR32","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1007\/s11606-020-06063-y","volume":"35","author":"AR Green","year":"2020","unstructured":"Green AR, Boyd CM, Gleason KS, et al. Designing a primary care\u2013based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study. J Gen Int Medicine. 2020;35:3556-3563.","journal-title":"J Gen Int Medicine."},{"key":"9346_CR33","unstructured":"Boyd RW, Lindo EG, Weeks LD, McLemore MR. On racism: a new standard for publishing on racial health inequities. Health Aff Forefront. 2020;"},{"issue":"2","key":"9346_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1370\/afm.2943","volume":"21","author":"Y Zisman-Ilani","year":"2023","unstructured":"Zisman-Ilani Y, Khaikin S, Savoy ML, et al. Disparities in shared decision-making research and practice: the case for black American patients. Ann Fam Med. 2023;21(2):112-118.","journal-title":"Ann Fam Med."},{"issue":"1","key":"9346_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12877-021-02249-z","volume":"21","author":"S Crutzen","year":"2021","unstructured":"Crutzen S, Abou J, Smits SE, et al. Older people\u2019s attitudes towards deprescribing cardiometabolic medication. BMC geriatr. 2021;21(1):366.","journal-title":"BMC geriatr."},{"issue":"12","key":"9346_CR36","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jamainternmed.2018.4720","volume":"178","author":"E Reeve","year":"2018","unstructured":"Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Int Med. 2018;178(12):1673-1680.","journal-title":"JAMA Int Med."},{"key":"9346_CR37","unstructured":"National Center for Veterans Analysis and Statistics. Profile of Veterans 2017; 2019."},{"issue":"10","key":"9346_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.7326\/M21-4204","volume":"175","author":"HB Mehta","year":"2022","unstructured":"Mehta HB, Li S, An H, Goodwin JS, Alexander GC, Segal JB. Development and validation of the summary Elixhauser Comorbidity Score for use with ICD-10-CM\u2013coded data among older adults. Ann Int Med. 2022;175(10):1423-1430.","journal-title":"Ann Int Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09346-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:02:46Z","timestamp":1769648566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09346-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9346"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09346-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Dr. Miller reported receiving grants from US Department of Veterans Affairs (VA) during the conduct of the study. Dr. Bokhour reported receiving grants from VA Health Services Research and development during the conduct of this study. Dr. Linsky reported receiving personal fees from the National Institute on Aging for presenting at the US Deprescribing Research Network Annual Meeting, and from the Agency for Healthcare Research and Quality of authoring a chapter on deprescribing for Making Healthcare Sager IV outside the submitted work. There are no other disclosures reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}